Professor Herbert Herzog Related News
Large NHMRC grant supports study of genes that affect appetite in flies, mice and humans
02 Nov 2011
Neuroscientists at Garvan have been awarded a $1,840,000 five-year project grant from Australia’s main medical research funding body, the National Health and Medical Research Council. Ranked within the top 3 out of 3,500 project applications, the study will screen the whole genome of the fruit fly, looking for genes that affect appetite and energy expenditure, which are also ‘conserved’ across species.
A powerful gut hormone that affects insulin and blood sugar levels
MEDIA RELEASE:
16 Jun 2010
Garvan researchers, in collaboration with English colleagues, have shown that a gut hormone released after we eat determines the speed at which we digest food and absorb nutrients across the gut into our blood. This makes it very influential in disorders such as Type 2 diabetes, and a promising therapeutic target.
We now know that the brain controls the formation of bone
MEDIA RELEASE:
22 Dec 2009
New findings show that bone formation, far from being a straightforward mechanical process dependent on body weight, is delicately orchestrated by the brain, which sends and receives signals through the body’s neural and hormone systems.
New weight loss approach targets the body and not the brain
MEDIA RELEASE:
25 Nov 2009
Current drug-based weight loss therapies try to stop the brain from sending hunger signals to the body. These therapies tend to be fairly ineffective, Garvan researchers reasoned, so why not reverse the approach and stop the body from receiving signals from the brain? So that’s what they did, and it worked. In mice at least.
Professor Herbert Herzog wins prestigious award
14 Jan 2009
Professor Herbert Herzog, Head of Garvan’s Neuroscience program, will receive the Viktor Mutt Award later this month from the International Regulatory Peptide Society for his substantial contributions in the field of peptide research, particularly in Neuropeptide Y (NPY) research.
Importance of sex-specific testing shown in anxiety study
MEDIA RELEASE:
15 Oct 2008
A Garvan scientist has flagged an important truth for the medical research community. Like their human counterparts, male and female mice are not only different, their respective genetic responses can often be the reverse of what you'd expect from pharmacological results. This has important ramifications for laboratory and clinical testing.
Low levels of PYY hormone a very early indicator of Type 2 diabetes
MEDIA RELEASE:
10 Mar 2008
Garvan scientists have published findings showing that low levels of the hormone PYY could be used as a predictor for the development of Type 2 diabetes. Clinical studies have shown that people with a family history of Type 2 diabetes, but not yet showing signs of insulin resistance themselves, produce lower levels of PYY after eating, a very early sign of pre-diabetes.
Natural gut hormones may provide a treatment for obesity
MEDIA RELEASE:
08 Jan 2008
Garvan researchers have shown that a hormone released naturally from the gut could be used to treat obesity and Type 2 diabetes. After a meal, the hormone peptide YY (PYY) is released from the gut and acts on the brain, contributing to a feeling of satiety. Researchers foresee the use of this hormone as a weight loss medication.
The molecule that can switch appetite off and on
05 Nov 2007
Researchers from the St Vincent’s Campus have identified the molecule responsible for the extreme weight loss common in late stage cancer. The findings published online in Nature Medicine suggest it may soon be possible to prevent this condition, giving people the strength to survive treatment. Conversely, the knowledge also suggests a way to switch off appetite in obese people.
How we can stop stress from making us obese
02 Jul 2007
Neuropeptide Y (NPY), a molecule the body releases when stressed, can ‘unlock’ Y2 receptors in the body’s fat cells, stimulating the cells to grow in size and number.
Great opportunity for Garvan neuroscientist
30 Dec 2005
Dr Deborah Lin, a researcher in the Neuroscience program, has been awarded a full travel bursary to attend a training program at Japan’s prestigious RIKEN Brain Science Institute
Garvan researchers explain how stress makes us sick
05 Dec 2005
Garvan Institute scientists have discovered how a hormone known as neuropeptide Y (NPY) can prevent our immune system functioning properly paving the way for new opportunities for therapeutic intervention.
